A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging

Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...

Podrobná bibliografie
Hlavní autoři:	Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N
Médium:	Journal article
Vydáno:	Wiley 2018

Podobné jednotky

No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
Autor: Andrea Hartner, a další
Vydáno: (2023-06-01)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
Autor: Chan, M, a další
Vydáno: (2016)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
Autor: Yeh, TL, a další
Vydáno: (2017)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
Autor: McNeill, L, a další
Vydáno: (2002)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Autor: Mole, D, a další
Vydáno: (2003)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Autor: Cockman, M, a další
Vydáno: (2019)

Regulation of HIF: prolyl hydroxylases.
Autor: Stolze, I, a další
Vydáno: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Autor: Chowdhury, R, a další
Vydáno: (2016)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
Autor: Schlemminger, I, a další
Vydáno: (2003)

Inhibition of a viral prolyl hydroxylase
Autor: Langley, G, a další
Vydáno: (2019)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
Autor: Chowdhury, R, a další
Vydáno: (2013)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Autor: Matthew E Cockman, a další
Vydáno: (2019-09-01)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
Autor: Holt-Martyn, JP, a další
Vydáno: (2019)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
Autor: Lippl, K, a další
Vydáno: (2015)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Autor: Rasheduzzaman Chowdhury, a další
Vydáno: (2016-08-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Autor: Tuckerman, JR, a další
Vydáno: (2004)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
Autor: Willam, C, a další
Vydáno: (2006)

Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding
Autor: Thinnes, C, a další
Vydáno: (2018)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
Autor: Chen, R, a další
Vydáno: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
Autor: Chen, R, a další
Vydáno: (2014)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Autor: Flashman, E, a další
Vydáno: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
Autor: Moritz J. Strowitzki, a další
Vydáno: (2021-04-01)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
Autor: Astuti, D, a další
Vydáno: (2010)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
Autor: Masson, N, a další
Vydáno: (2003)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
Autor: Holt-Martyn, J, a další
Vydáno: (2019)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
Autor: Masson, N, a další
Vydáno: (2004)

Prolyl hydroxylases and therapeutics.
Autor: Smith, T, a další
Vydáno: (2010)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
Autor: Wijeyekoon, JB
Vydáno: (2013)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
Autor: Maria Savyuk, a další
Vydáno: (2020-07-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Autor: Andrey A. Poloznikov, a další
Vydáno: (2021-01-01)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
Autor: Singh, A, a další
Vydáno: (2020)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
Autor: Yeoh, K, a další
Vydáno: (2013)

Oxygen sensing by HIF hydroxylases.
Autor: Schofield, C, a další
Vydáno: (2004)

Signalling hypoxia by HIF hydroxylases.
Autor: Schofield, C, a další
Vydáno: (2005)

Studies on the substrate selectivity of the hypoxia-inducible factor prolyl hydroxylase 2 catalytic domain
Autor: Abboud, M, a další
Vydáno: (2018)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
Autor: Richardson, NL, a další
Vydáno: (2021)

Therapeutic manipulation of the HIF hydroxylases.
Autor: Nagel, S, a další
Vydáno: (2010)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
Autor: Mecinovic, J, a další
Vydáno: (2007)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
Autor: Lippl, K
Vydáno: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
Autor: Takahiro Kambara, a další
Vydáno: (2024-03-01)